Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$0.28 - $1.16 $90 - $375
324 Added 18.22%
2,102 $1,000
Q1 2024

Apr 05, 2024

SELL
$1.06 - $1.67 $667 - $1,052
-630 Reduced 26.16%
1,778 $2,000
Q4 2023

Feb 01, 2024

SELL
$1.26 - $1.79 $13,378 - $19,006
-10,618 Reduced 81.51%
2,408 $4,000
Q3 2023

Oct 11, 2023

BUY
$1.61 - $2.54 $2,043 - $3,223
1,269 Added 10.79%
13,026 $24,000
Q2 2023

Aug 03, 2023

BUY
$1.14 - $1.95 $12,893 - $22,054
11,310 Added 2530.2%
11,757 $22,000
Q1 2023

Apr 28, 2023

SELL
$1.2 - $2.19 $2,673 - $4,879
-2,228 Reduced 83.29%
447 $1,000
Q4 2022

Feb 01, 2023

BUY
$1.63 - $3.52 $3,631 - $7,842
2,228 Added 498.43%
2,675 $5,000
Q3 2022

Oct 27, 2022

SELL
$0.73 - $3.74 $73 - $374
-100 Reduced 18.28%
447 $1,000
Q2 2022

Jul 28, 2022

BUY
$2.2 - $4.2 $1,203 - $2,297
547 New
547 $1,000
Q1 2022

Apr 21, 2022

SELL
$2.83 - $8.69 $1,548 - $4,753
-547 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$8.31 - $14.92 $4,545 - $8,161
547 New
547 $5,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.